Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

CLDI - Calidi Biotherapeutics Inc - Ordinary Shares - Class A


Close
1.14
0.040   3.509%

Share volume: 78,832
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$1.10
0.04
3.64%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
1.33%
1 Month
-28.75%
3 Months
-62.00%
6 Months
-86.41%
1 Year
-81.00%
2 Year
-88.61%
Key data
Stock price
$1.14
P/E Ratio 
0.00
DAY RANGE
$1.09 - $1.15
EPS 
$0.00
52 WEEK RANGE
$1.01 - $50.00
52 WEEK CHANGE
-$0.88
MARKET CAP 
9.216 M
YIELD 
N/A
SHARES OUTSTANDING 
8.084 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$171,627
AVERAGE 30 VOLUME 
$139,853
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news